MIMOSAPHARMA
ActiveSummary
MIMOSAPHARMA has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,738 and a net result of €24,738. Its solvency ranks better than 95% of 12,678 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
2026
19-06
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2024
26-11
Gazette deed
IncorporationFounding capital · Bank account · Share issue4 facts ▸
Gazette deed
Incorporation
Founding capital · Bank account · Share issue4 facts ▸
- Incorporation, “MIMOSAPHARMA” (deed in French)
- Founding capital, €5,000
- Bank account, EUR, “compte spécial ouvert au nom de la société en formation” (deed in French)
- Share issue, 100, “1 à 100” (deed in French)
Gazette deedNBB filing
1 of 1 deed read